Axtria, a global big data analytics company, is pleased to announce a strategic agreement with Boehringer Ingelheim (a top 20 pharmaceutical manufacturer) to provide end-to-end Incentive Compensation services to its global commercial teams. As part of the agreement, over 12,000 users across Boehringer Ingelheim’s global markets will be deployed on Axtria’s SalesIQ. There are already 3,500 users in the US and Japan live on the platform today.
Previously, all bonus and incentive processes at Boehringer Ingelheim were localized within each business unit and region. With a focus on driving field force effectiveness, Boehringer Ingelheim aims to standardize on a modern, enterprise-grade platform that aligns compensation strategies and implements best practices globally.
“Axtria proved that they not only have a strong platform and experience to deploy in an agile way a state of the art bonuses and incentives platform but also proved they have a strong global experience on how to bring to the next level Customer Facing Roles motivation through bonuses and incentives therefore impacting their productivity and effectiveness.” said Dave Arnold, Head of Customer Engagement Excellence at Boehringer Ingelheim.
Axtria SalesIQ is an integrated, cloud based sales planning and operations platform covering Territory Alignment, Call Planning, Incentive Compensation and Field Reporting. It is built on the Salesforce.com platform and integrates natively with Veeva CRM.
As part of the transformation, Boehringer Ingelheim expects Axtria SalesIQ to deliver:
“We are excited to be partnering with Boehringer Ingelheim on this strategic initiative” said Jassi Chadha, Founder and CEO of Axtria. “This is a testament to the impact that our cloud solutions have on Commercial Operations processes. We look forward to delivering on the vision, improving field force effectiveness and incentivizing the right behaviors across the globe.”
To learn more about Axtria and their cloud solutions, please visit www.axtria.com
Andrew Keleher, Senior Director of Marketing
About Boehringer Ingelheim
Boehringer Ingelheim is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally through 145 affiliates and a total of some 47,500 employees. The focus of the family-owned company, founded in 1885, is on researching, developing, manufacturing and marketing new medications of high therapeutic value for human and veterinary medicine.
Axtria is a global big data analytics company. We help leaders across the Life Sciences and Financial Services industries make better data-driven decisions. We help to optimize business strategy by delivering cutting edge analytics from the broadest set of data sources, combined with deep technical and domain expertise. We enable commercial excellence by eliminating spreadsheets and delivering analytical guidance to the field through Axtria SalesIQ, our cloud based sales planning and operations platform. We are leaders in managing data using the latest cloud information management and big data technologies. We have more than 800 employees worldwide, we are growing rapidly, and we are proud to count 8 of the top 10 global Life Sciences companies and 2 of the Top 5 global banks as our customers.
Axtria and Axtria SalesIQ are registered trademarks of Axtria. Other names may be trademarks of their respective owners.